Literature DB >> 21396254

In-vivo activity of dihydroartemisinin against Schistosoma japonicum.

H-J Li1, W Wang, G-L Qu, Y-H Tao, Y-T Xing, Y-Z Li, J-Y Wei, J-R Dai, Y-S Liang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21396254      PMCID： PMC4084662          DOI： 10.1179/136485911X12899838683287

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN： 0003-4983


× No keyword cloud information.
  25 in total

Review 1.  Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins.

Authors:  Shu-Hua Xiao
Journal:  Acta Trop       Date:  2005-08-19       Impact factor: 3.112

2.  Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial.

Authors:  J Utzinger; E K N'Goran; A N'Dri; C Lengeler; S Xiao; M Tanner
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

3.  The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China.

Authors:  Hai-Yong Hua; You-Sheng Liang; Yan Zhang; Ji-Fu Wei; Hong-Xiong Guo
Journal:  Parasitol Res       Date:  2010-06-15       Impact factor: 2.289

4.  Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.

Authors:  J Utzinger; J Chollet; J You; J Mei; M Tanner; S Xiao
Journal:  Acta Trop       Date:  2001-09-01       Impact factor: 3.112

Review 5.  Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience.

Authors:  Ming-Gang Chen
Journal:  Acta Trop       Date:  2005-08-25       Impact factor: 3.112

6.  Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China.

Authors:  D B Yu; Y Li; A C Sleigh; X L Yu; Y S Li; W Y Wei; Y S Liang; D P McManus
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Sep-Oct       Impact factor: 2.184

7.  [Pharmacokinetics of dihydroqinghaosu in human volunteers and comparison with qinghaosu].

Authors:  K C Zhao; Z Y Song
Journal:  Yao Xue Xue Bao       Date:  1993

Review 8.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

9.  Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.

Authors:  P G Fallon; R F Sturrock; A C Niang; M J Doenhoff
Journal:  Am J Trop Med Hyg       Date:  1995-07       Impact factor: 2.345

10.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18
View more
  10 in total

1.  Radicicol, a Novel Lead Compound against the Migratory-Stage Schistosomula of Schistosoma japonicum.

Authors:  Liangxiong Xu; Qiuli Liu; Qingren Zeng; Ping Wu; Quan Yu; Kongzhen Gu; Jinghua Xue; Xiaoyi Wei
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.

Authors:  Hong-jun Li; Wei Wang; Guo-li Qu; You-zi Li; Yong-hui Tao; Yun-tian Xing; Xiao-ting Wang; Yang Dai; Jian-ying Wei; Jian-rong Dai; Gerald C Coles; You-sheng Liang
Journal:  Parasitol Res       Date:  2011-10-18       Impact factor: 2.289

3.  Dihydroartemisinin-praziquantel combinations and multiple doses of dihydroartemisinin in the treatment of Schistosoma japonicum in experimentally infected mice.

Authors:  H-J Li; W Wang; Y-H Tao; G-L Qu; Y-T Xing; Y-Z Li; J-Y Wei; J-R Dai; Y-S Liang
Journal:  Ann Trop Med Parasitol       Date:  2011-06

Review 4.  A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.

Authors:  Xu-Guang Zhang; Gui-Xin Li; Shu-Shun Zhao; Fu-Liang Xu; Yun-Hai Wang; Wei Wang
Journal:  Parasitol Res       Date:  2014-03-08       Impact factor: 2.289

5.  Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum.

Authors:  Hong-Jun Li; Wei Wang; You-Zi Li; Guo-Li Qu; Yun-Tian Xing; Yong-Hui Tao; Jian-Ying Wei; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2011-05-28       Impact factor: 2.289

6.  Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?

Authors:  Wei Wang; Hong-Jun Li; Guo-Li Qu; Yun-Tian Xing; Zhen-Kun Yang; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

7.  Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection.

Authors:  Hong-Jun Li; Fu-Liang Xu; Yun-Hai Wang; Zheng-Jun Yi; Wei Wang
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

Review 8.  Repurposing drugs for the treatment and control of helminth infections.

Authors:  Gordana Panic; Urs Duthaler; Benjamin Speich; Jennifer Keiser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-07-30       Impact factor: 4.077

9.  Natural products as leads in schistosome drug discovery.

Authors:  Bruno J Neves; Carolina H Andrade; Pedro V L Cravo
Journal:  Molecules       Date:  2015-01-23       Impact factor: 4.411

Review 10.  New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China.

Authors:  Yi-Xin Liu; Wei Wu; Yue-Jin Liang; Zu-Liang Jie; Hui Wang; Wei Wang; Yi-Xin Huang
Journal:  Molecules       Date:  2014-09-19       Impact factor: 4.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.